AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells.

Lee, Dakeun; Yu, Eun Ji; Ham, In-Hye; Hur, Hoon; Kim, You-Sun

Lee, Dakeun; Yu, Eun Ji; Ham, In-Hye; Hur, Hoon; Kim, You-Sun.

Affiliation

Lee D; Department of Pathology, Ajou University School of Medicine, Suwon, Republic of Korea.
Yu EJ; Department of Pathology, Ajou University School of Medicine, Suwon, Republic of Korea.
Ham IH; Department of Surgery, Ajou University School of Medicine, Suwon, Republic of Korea.
Hur H; Brain Korea 21 Plus Research Center for Biomedical Sciences, Ajou University, Suwon, Republic of Korea.
Kim YS; Department of Surgery, Ajou University School of Medicine, Suwon, Republic of Korea.

Onco Targets Ther ; 10: 4153-4159, 2017.

Article de En | MEDLINE | ID: mdl-28860825

Mots clés

AKT inhibitor; ARID1A; chemotherapy; gastric cancer

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Onco Targets Ther Année: 2017 Type de document: Article Pays de publication: Nouvelle-Zélande

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google